News
12d
News Medical on MSNNK cells with bispecific antibody yield high response rates in patients with lymphoma: Clinical trialA novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a ...
Taconic Biosciences prioritizes accessibility and efficiency in preclinical research. Unlike other providers, Taconic does ...
It also develops SENTI-401, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate colorectal ...
The NK cells first are activated with cytokines ... and vice president and head of MD Anderson’s Institute for Cell Therapy Discovery & Innovation. Through the institute, Rezvani and her ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results